Linli Hu

ORCID: 0000-0001-9069-2466 · 20 papers in corpus
rct 2025
Nature communications ·doi:10.1038/s41467-025-67714-4

Advanced maternal age (AMA, ≥35 years) women undergoing assisted reproductive technology (ART) face reduced live birth rates (LBR) and remain a major clinical challenge. In a large randomized trial, Zishen Yutai Pill (ZYP) improved LBR in t…

observational 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.564344

Oocyte retrieval is a routine procedure during the application of assisted reproduction technology. However, technical difficulties experienced during oocyte retrieval and the subsequent unsatisfactory number of oocytes obtained are rarely …

observational 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.655803

BACKGROUND: Some studies have demonstrated that adenomyosis patients can achieve a comparable pregnancy outcome with women with normal uteruses, while there is no unanimous conclusion at present. METHOD: We recruited 65 adenomyosis patient…

observational 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.706427

BACKGROUND: Progesterone administration before transfer in hormone replacement treatment (HRT) is crucial to pregnancy outcomes in frozen-thawed blastocyst transfer (FET), but the optimal progesterone duration is inconsistent. The objective…

observational 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00678-w

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a common disease during controlled ovarian hyperstimulation treatment. However, the obstetric and neonatal outcomes of this group of patients are unknown. The aim of this study was to …

nonrandomized-trial 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00469

Background: Studies have shown that patients with a thin endometrial thickness (EMT < 7 or 8 mm) during IVF/ICSI tend to have adverse pregnancy outcomes, and this has caused much anxiety to both patients and physicians when confronted with …

2020
·doi:10.21203/rs.3.rs-64858/v1

Abstract Persistent supraphysiological serum estradiol (E2) levels during controlled ovarian hyper-stimulation (COH) have a detrimental effect on endometrial receptivity. In this study, we explored RNA expression and DNA methylation profile…

observational 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.615957

INTRODUCTION: Age, polycystic ovary syndrome (PCOS), low body mass index (BMI), high antral follicle count (AFC), increased anti-Muller hormone (AMH) levels, and elevated serum estradiol (E2) concentrations are risk factors for ovarian hype…

observational 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2019.11.001

RESEARCH QUESTION: Which factors are related to early spontaneous miscarriage in IVF-conceived clinical pregnancies? DESIGN: A total of 21,485 clinical pregnancies were included in the analysis. First, early spontaneous miscarriage rates w…

observational 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01849-9

PURPOSE: The study aimed to investigate the relationship between elevated maternal body mass index (BMI) and foetal chromosomal aberrations by performing single-nucleotide polymorphism (SNP) array-based genetic testing on products of concep…

observational 2020
Aging ·doi:10.18632/aging.103151

We investigated the effects of paternal characteristics, including age, body mass index (BMI), and semen parameters on chromosomal aberration-related miscarriages in couples that underwent treatment with assisted reproductive technology (AR…

observational 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.536100

BACKGROUND: When ovarian response to FSH stimulation for IVF/ICSI is unsatisfactory, the FSH dose is often adjusted in the treatment cycles, thereby assuming that hormone status and follicular development were insufficient for optimal stimu…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00834

Background: Polycystic ovary syndrome (PCOS) patients have a better ovarian reserve and age-related improvement in endocrine disturbances than non-PCOS patients. The effects of age on in vitro fertilization (IVF) treatment outcomes associat…

observational 2019
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/MSM.916447

BACKGROUND Patients with endometriosis (EMs) are routinely advised to take GnRH-a for 3-6 months to improve the internal reproductive environment, but this may not be necessary. MATERIAL AND METHODS This retrospective study examined the eff…

observational 2019
·doi:10.12659/msm.916447

BACKGROUND: Patients with endometriosis (EMs) are routinely advised to take GnRH-a for 3–6 months to improve the internal reproductive environment, but this may not be necessary. MATERIAL/METHODS: This retrospective study examined the effec…

rct 2018
Reproductive health ·doi:10.1186/s12978-018-0639-8

BACKGROUND: Endometriosis is the major cause of progressive pelvic pain and subfertility. Up to 50% of reproductive-age women suffer from pelvic pain. Endometriosis is a classic indication for IVF. Compared with women whose inability to pro…

2018
·doi:10.1016/j.fertnstert.2018.07.1118
observational 2014
International journal of clinical and experimental medicine

Many protocols have been proposed to improve IVF outcomes for poor ovarian responders. The aim of this study was to explore the relationship between age, ovarian hyperstimulation protocol and IVF/ICSI outcomes in poor ovarian responder (POR…

observational 2014
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-013-0129-4

PURPOSE: To identify the independent predictors of live birth following IVF, and to assess the role of cohort-specific parameters, including antral follicle count (AFC), the number of oocytes retrieved, the total number of embryos, and the …

lab-animal 2014
Fertility and sterility ·doi:10.1016/j.fertnstert.2014.05.036

OBJECTIVE: To identify the expression profile and sex steroid regulation pattern of myeloid ecotropic viral integration site 1 (MEIS1) in endometrium. DESIGN: Molecular studies in human and animal tissue. SETTING: Reproductive medicine ce…